Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Non-Current Assets (2016 - 2024)

Tenax Therapeutics' Non-Current Assets history spans 6 years, with the latest figure at $1.8 million for Q4 2017.

  • On a quarterly basis, Non-Current Assets fell 81.18% to $1.8 million in Q4 2017 year-over-year; TTM through Dec 2017 was $15.0 million, a 91.09% decrease, with the full-year FY2017 number at $1.8 million, down 81.18% from a year prior.
  • Non-Current Assets hit $1.8 million in Q4 2017 for Tenax Therapeutics, down from $2.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for TENX hit a ceiling of $54.0 million in Q2 2016 and a floor of $1.3 million in Q2 2013.
  • Historically, Non-Current Assets has averaged $18.6 million across 4 years, with a median of $5.4 million in 2017.
  • Biggest five-year swings in Non-Current Assets: dropped 10.71% in 2013 and later tumbled 95.5% in 2017.
  • Tracing TENX's Non-Current Assets over 4 years: stood at $1.3 million in 2013, then soared by 3817.14% to $52.4 million in 2015, then plummeted by 81.48% to $9.7 million in 2016, then tumbled by 81.18% to $1.8 million in 2017.
  • Business Quant data shows Non-Current Assets for TENX at $1.8 million in Q4 2017, $2.3 million in Q3 2017, and $4.5 million in Q2 2017.